* patient requiring normal hospitalization or intensive care * oxygen-requiring patient, * with a history of parasitosis, in particular filariasis, * with a history of hypereosinophilia, * notion of recent travel (less than 3 months) in poor hygienic conditions * taking ivermectin in the last 12 months, * contraindications to ivermectin or one of the constituents of the drug (known history of allergies), * pregnant or breastfeeding women, * participation in another interventional study relating to covid-19 concerning a drug during this research, * patient under ame or without social security coverage.

* patient requiring normal hospitalization or intensive care * oxygen-requiring patient, * with a history of parasitosis, in particular filariasis, * with a history of hypereosinophilia, * notion of recent travel (less than 3 months) in poor hygienic conditions * taking ivermectin in the last 12 months, * contraindications to ivermectin or one of the constituents of the drug (known history of allergies), * pregnant or breastfeeding women, * participation in another interventional study relating to covid-19 concerning a drug during this research, * patient under ame or without social security coverage.

- patient requiring normal hospitalization or intensive care - oxygen-requiring patient, - with a history of parasitosis, in particular filariasis, - with a history of hypereosinophilia, - notion of recent travel (less than 3 months) in poor hygienic conditions - taking ivermectin in the last 12 months, - contraindications to ivermectin or one of the constituents of the drug (known history of allergies), - pregnant or breastfeeding women, - participation in another interventional study relating to covid-19 concerning a drug during this research, - patient under ame or without social security coverage.

- patient requiring normal hospitalization or intensive care - oxygen-requiring patient, - with a history of parasitosis, in particular filariasis, - with a history of hypereosinophilia, - notion of recent travel (less than 3 months) in poor hygienic conditions - taking ivermectin in the last 12 months, - contraindications to ivermectin or one of the constituents of the drug (known history of allergies), - pregnant or breastfeeding women, - participation in another interventional study relating to covid-19 concerning a drug during this research, - patient under ame or without social security coverage.